Cargando…
“A Tale of Two Cities”: Anticoagulation Management in Patients with Atrial Fibrillation and Prosthetic Valves in the Era of Direct Oral Anticoagulants
Valvular heart disease and atrial fibrillation often coexist. Oral vitamin K antagonists have represented the main anticoagulation management for antithrombotic prevention in this setting for decades. Novel direct oral anticoagulants (DOACs) are a new class of drugs and currently, due to their well-...
Autores principales: | Palmiero, Giuseppe, Melillo, Enrico, Rubino, Antonino Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722984/ https://www.ncbi.nlm.nih.gov/pubmed/31382702 http://dx.doi.org/10.3390/medicina55080437 |
Ejemplares similares
-
Anticoagulation for Prosthetic Valves
por: Kaneko, Tsuyoshi, et al.
Publicado: (2013) -
Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016) -
Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019) -
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
por: Abdelnabi, Mahmoud, et al.
Publicado: (2020) -
Systematic Review and Meta-Analysis: Can We Compare Direct Oral Anticoagulants to Warfarin in Patients With Atrial Fibrillation and Bio-Prosthetic Valves?
por: Adhikari, Govinda, et al.
Publicado: (2021)